These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3278582)

  • 1. Usefulness of aspirin for coronary artery disease.
    Fuster V; Cohen M; Chesebro JH
    Am J Cardiol; 1988 Mar; 61(8):637-40. PubMed ID: 3278582
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
    Patrono C
    Eur Heart J; 1986 Jun; 7(6):454-9. PubMed ID: 3525167
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in cardiology. Proposed: low-dose aspirin should be taken daily after age 40 if total serum cholesterol is greater than 160.
    Schoenberger JA; Mann GV
    Hosp Pract (Off Ed); 1982 Dec; 17(12):50A, 50D, 50F passim. PubMed ID: 6815063
    [No Abstract]   [Full Text] [Related]  

  • 5. Who might benefit from early aspirin after coronary artery surgery?
    Gukop P; Gutman N; Bilkhu R; Karapanagiotidis GT
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):505-11. PubMed ID: 24871533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin and other antiplatelet drugs in the prophylaxis of thrombosis.
    Webster J; Douglas AS
    Blood Rev; 1987 Mar; 1(1):9-20. PubMed ID: 3332089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin, platelets and myocardial infarction--proposal for a trial.
    Williams WO; Elwood PC
    J R Coll Gen Pract; 1975 Nov; 25(160):844. PubMed ID: 772196
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
    Chong BH
    Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286
    [No Abstract]   [Full Text] [Related]  

  • 11. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW; Sutton GC
    Chest; 1998 Nov; 114(5 Suppl):611S-633S. PubMed ID: 9822067
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 14. Can aspirin prevent myocardial infarction?
    Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of intricate vascular and thrombocytic factors in precipitating acute coronary syndromes. Therapeutic implications].
    Popescu P; Nanea T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(6):509-18. PubMed ID: 2908154
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological prevention of coronary thrombosis].
    Spławińska B; Spławiński J
    Pol Tyg Lek; 1987 Jun; 42(26):795-801. PubMed ID: 3313320
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin and ischaemic heart disease.
    Br J Hosp Med; 1986 Aug; 36(2):85. PubMed ID: 3527318
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
    Borhani NO
    JAMA; 1985 Jul; 254(2):257-62. PubMed ID: 2860255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.